Schizophrenia Research
Volume 119, Issue 1 , Pages 228-231 , June 2010

Antipsychotic drug use is correlated with CRP40/mortalin mRNA expression in the dorsolateral prefrontal cortex of human postmortem brain specimens

  • Joseph P. Gabriele

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationCorresponding author. McMaster University, 1200 Main St. West, HSC Rm 4N81, Hamilton, Ontario, Canada L8N 3Z5. Tel.: +1 905 525 9140x22617.
    • ,
  • Giuseppe F. Pontoriero

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Nancy Thomas

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Mark A. Ferro

      Affiliations

    • Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada
    • ,
  • Geetha Mahadevan

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Duncan J. MacCrimmon

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Zdenek B. Pristupa

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Ram K. Mishra

      Affiliations

    • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada

Received 15 July 2009 ,Revised 21 December 2009 ,Accepted 29 December 2009.

References 

  1. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 2000;31(2–3):251–269
  2. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex. 2000;10(11):1078–1092
  3. Gabriele J, Rajaram M, Zhang B, Sharma S, Mishra RK. Modulation of a 40-kDa catecholamine-regulated protein following d-amphetamine treatment in discrete brain regions. Eur. J. Pharmacol. 2002;453(1):13–19
  4. Gabriele JP, Chong VZ, Pontoriero GF, Mishra RK. Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium. Schizophr. Res. 2005;74(1):111–119
  5. Gabriele J, Pontoriero GF, Thomas N, Thomson CA, Skoblenick K, Pristupa ZB, et al. Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders. Cell Stress Chaperones. 2009;
  6. Glahn DC, Bearden CE, Barguil M, Barrett J, Reichenberg A, Bowden CL, et al. The neurocognitive signature of psychotic bipolar disorder. Biol. Psychiatry. 2007;62(8):910–916
  7. Modi PI, Kashyap A, Nair VD, Ross GM, Fu M, Savelli JE, et al. Modulation of brain catecholamine absorbing proteins by dopaminergic agents. Eur. J. Pharmacol. 1996;299(1–3):213–220
  8. Nair VD, Mishra RK. Molecular cloning, localization and characterization of a 40-kDa catecholamine-regulated protein. J. Neurochem. 2001;76(4):1142–1152
  9. Pira L, Mongeau R, Pani L. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Eur. J. Pharmacol. 2004;504(1–2):61–64
  10. Ross GM, McCarry BE, Thakur S, Mishra RK. Identification of novel catecholamine absorbing proteins in the central nervous system. J. Mol. Neurosci. 1993;4(3):141–148
  11. Ross GM, McCarry BE, Mishra RK. Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene. J. Neurochem. 1995;65(6):2783–2789
  12. Seeman P, Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U. S. A. 2000;97(14):7673–7675
  13. Selemon LD, Rajkowska G. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr. Mol. Med. 2003;3(5):427–436
  14. Sharan N, Chong VZ, Nair VD, Mishra RK, Hayes RJ, Gardner EL. Cocaine treatment increases expression of a 40kDa catecholamine-regulated protein in discrete brain regions. Synapse. 2003;47(1):33–44
  15. Van Laar VS, Mishizen AJ, Cascio M, Hastings TG. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells. Neurobiol. Dis. 2009;34(3):487–500
  16. Weinberger DR. Schizophrenia and the frontal lobe. Trends Neurosci. 1988;11(8):367–370
  17. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry. 2001;50(11):825–844

PII: S0920-9964(10)00006-X

doi: 10.1016/j.schres.2009.12.039

Schizophrenia Research
Volume 119, Issue 1 , Pages 228-231 , June 2010

Article Tools

* Image Usage & Resolution